What is Cabozantinib?

Category: Prescription Drugs

Most popular types: Cometriq

false

Cabozantinib is a targeted chemotherapy drug used for treatment of metastatic medullary thyroid carcinoma.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe
0
Moderate
1
Mild
0
None
3

Commonly reported side effects and conditions associated with Cabozantinib

Side effect Patients
Change in hair color 1
Diarrhea 1
Dizziness and feeling faint 1
Fatigue 1
Hair loss 1
Muscle weakness 1

Show all 8 reported side effects

Dosages

Based on patients currently taking Cabozantinib

Dosage Patients
60 mg daily 1

Duration

Currently taking Cabozantinib

Duration Patients
1 - 2 years 1
Adherence
Adherence Evaluations
Always 3
Usually 1
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations
Very hard to take 0
Somewhat hard to take 1
A little hard to take 0
Not at all hard to take 3

What people switch to and from

Patients started taking Cabozantinib after stopping:

Treatment Patients
Axitinib (Inlyta) 1
Last updated:
There are no evaluations for Cabozantinib.